<DOC>
	<DOC>NCT00789646</DOC>
	<brief_summary>The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due to subconjunctival antibiotic and antifungal injection.</brief_summary>
	<brief_title>Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Corneal Ulcer</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features. 1. corneal epithelial defect with stromal infiltration 2. reaction in anterior chamber 3. positive for bacteria or fungus The patients have to receive subconjunctival antibiotic injection twice at least. The patients must be informed consent. The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs. The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection. Unable to cooperate with the treatment. Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>corneal ulcer</keyword>
	<keyword>painless</keyword>
	<keyword>subconjunctival injection</keyword>
	<keyword>antibiotics</keyword>
	<keyword>antifungal</keyword>
	<keyword>lidocaine</keyword>
</DOC>